Impact of PCSK9 Inhibitors on Lipid Profiles and Inflammatory Biomarkers in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

Yong Zhao, Hao Hu, Lan Xue

PDF(5122 KB)
For Authors|For Editors|For Reviewers
PDF(5122 KB)
Discovery Medicine ›› 2026, Vol. 38 ›› Issue (204) : 278-289. DOI: 10.24976/Discov.Med.202638204.22
Systematic Review

Impact of PCSK9 Inhibitors on Lipid Profiles and Inflammatory Biomarkers in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2026, 38(204): 278-289 https://doi.org/10.24976/Discov.Med.202638204.22

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(5122 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2026.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉